The present invention deals with innovative compounds and compositions for preventing and/or treating a newly discovered detrimental mechanism which blocks the endogenous myelin repair capacity of the adult nervous system (NS) in diseases associated with the expression of HERV W envelope protein (ENV) in particular of its MSRV subtype.